{"id":"W2284575850","doi":"10.1038/bjc.2016.21","title":"Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Oncology; Biomarker; Urology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003305302,0.0001691042,0.0008002458,0.000115784,0.00007332098,0.00001871281,0.00006998037,0.00004369241,0.0001161723],"category_scores_gemma":[0.0002170887,0.0001153735,0.0002451609,0.00007974691,0.00009556541,0.0001356415,0.00001929056,0.00009176804,1.823126e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001485443,"about_ca_system_score_gemma":0.0002440867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003922525,"about_ca_topic_score_gemma":0.00005682369,"domain_scores_codex":[0.9981691,0.00009373096,0.0008555976,0.000185928,0.0004657361,0.0002298995],"domain_scores_gemma":[0.9978967,0.0004011083,0.0008674982,0.0001179631,0.000488214,0.0002284964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7330748,0.00201395,0.08875702,0.0002604354,0.001532484,0.001015474,0.0002712494,0.000003679615,0.01548127,8.412466e-7,0.000336386,0.1572524],"study_design_scores_gemma":[0.8790612,0.01153282,0.09708143,0.001029302,0.001978048,0.0002683904,0.00004799679,0.00001502662,0.008584846,0.0000310741,0.0002042075,0.0001656076],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955811,0.002233933,0.0002867319,0.000123227,0.0001713601,0.001202397,0.0003361827,0.000004308833,0.00006079775],"genre_scores_gemma":[0.9976214,0.0001172564,0.00185354,0.00005528624,0.0001903504,0.00004795184,0.00001527373,0.0000327896,0.00006612042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1570868,"threshold_uncertainty_score":0.4704795,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02780223500681314,"score_gpt":0.2944268261468427,"score_spread":0.2666245911400296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}